About

Dorothy is a Strategic Advisor at Google DeepMind, and was formerly their Director of Public Engagement, leading strategy and partnerships across health, science, and public institutions. She has played a key role in major initiatives such as the AI for Science Fund and advises senior leaders on research ethics and responsible innovation.

Dorothy brings a rare combination of experience in technology, ethics, governance, and public engagement. Alongside her work at Google DeepMind, she has held senior roles at Google, Uber and Dropbox, and has worked with partners across the public, private, and research sectors. Whilst at Google, she created the industry’s first Transparency Report – now a standard used by nearly 90 companies to show how laws and company policies affect free expression and privacy online.

As Chief Executive Officer of UCLPartners, Chris leads our work as a health innovation partnership and provides executive oversight of the NHS Innovation Accelerator, working with its co-directors.

He joined UCLPartners in October 2021, initially as Director of our Health Innovation Network and National Director of the NHS Innovation Accelerator, before being appointed as UCLPartners Chief Executive Officer in February 2022.

Chris undertook specialist training in nephrology, critical care and internal medicine, and continues to practise as a consultant nephrologist at University College London and Royal Free Hospitals, where he is also Honorary Associate Professor of Nephrology at the UCL Centre for Nephrology.

He undertook research training in renal disease, genetics and physiology at UCL and INSERM Paris. He remained active in research through clinical trials, health services research and the use of artificial intelligence in predicting acute renal disease.

Previous leadership roles have included Training Director, Clinical Lead for Nephrology and Associate Medical Director of Royal Free London NHS Foundation Trust. He worked for four years as Divisional Director of Emergency Services in University College London Hospitals where he oversaw the acute care pathway, leading an extensive programme of transformation. In the latter role he also led the UCLH emergency care response during the COVID-19 pandemic. He founded and led London Acute Kidney Injury Network.

Chris has a strong interest in digital health, technology and data science and worked for five years as a senior clinical advisor to DeepMind and Google Health.

Prof Becky Shipley OBE oversees the development of our partnership work in research and early phase innovation. She joined UCLPartners in April 2024.

With a background in mathematics and engineering, Becky’s roles have included Director of the UCL Institute of Healthcare Engineering and Vice Dean (Health) for the UCL Faculty of Engineering Sciences.

In addition to her UCLPartners role Becky is currently Professor of Healthcare Engineering at UCL. Her research lies in the development of model-based techniques to better understand how diseased and damaged tissues function and repair, including in cancer and nerve injury, as well as data-driven models for predicting (patho)physiology. Becky is a passionate advocate for healthcare engineering and the translation of scientific discoveries into practice. Becky is Co-Director of CHIMERA – a research centre that brings together mathematics, statistics, engineering and computational sciences to develop new data-driven models of human physiology, to inform clinical design making in intensive care. She is also co-lead for the UCLH-UCL BRC Healthcare Engineering & Imaging Theme, and lead for the newly-funded EPSRC Centre for Doctoral Training in Digital Health Technologies.

Becky was awarded an OBE in 2021 for her role during the COVID-19 pandemic in designing and manufacturing non-invasive breathing aids for people with the disease. These breathing aids, known as UCL-Ventura, have been deployed to over 130 NHS hospitals to treat patients as well as across 30 countries.

John Craig is Chief Innovation Officer at UCLPartners, leading its work to deliver proven innovations at scale in the NHS. John is also responsible for developing research-translation and innovation capability across UCLPartners. John’s work includes major implementation projects on equality in cancer care, deploying AI for prevention and achieving a step-change in reducing heart attacks and strokes.

John has spent two decades working on public service innovation. Before UCLPartners, he was Chief Executive of Care City, an innovation centre in Barking, North-East London, focused on care and regeneration. John has worked with FutureGov, the Cabinet Office’s Policy Lab, Shelter and Stonewall. Until 2015, John spent five years leading Innovation Unit, an independent non-profit that develops radically better, lower-cost public services.

Kevin is our Chief Medical Officer, providing an experienced clinical voice to our executive team, and steering our strategic development and project development.  He also supports our approach to clinical governance, ensuring our work has clinical impact and is steered by the clinical workforce.  Kevin’s role includes overseeing our innovation horizon scanning, policy, engagement and advocacy work.

In addition to his role at UCLPartners, Kevin is Professor of Innovation and Engagement for Science and Medicine in the UCL Department of Science, Technology, Engineering and Public Policy.  He works as a consultant anaesthetist in UCLH and flies as a doctor with a Helicopter Emergency Medical Service crew at Air Ambulance Charity  Kent Surrey Sussex (AAKSS).

Kevin has previously been a NESTA fellow, a visiting researcher with NASA and a Wellcome Trust  Fellow in public engagement.  He also worked as National Clinical Adviser in Emergency Preparedness, Resilience and Response (EPRR) for NHS England during the COVID-19 pandemic. Since then, he has provided great advocacy regarding the impact the pandemic has had on the wellbeing and mental health of NHS staff.

Kate Petts is Chief Transformation Officer at UCLPartners, where she leads programmes that deliver large-scale transformation and sustainable, measurable change across health and care systems. Her work focuses on integrating proven solutions into whole-pathway and system-wide change, helping healthcare providers and commissioners reduce fragmentation, improve patient outcomes and build more sustainable services for the future.

Kate has extensive experience in both operational and strategic leadership roles across the NHS in London and the East of England. Beginning her career as a critical care physiotherapist, she combines frontline clinical insight with expertise in transformation, service redesign and system improvement. She is passionate about translating innovation into practice at scale, ensuring that evidence-based approaches are embedded sustainably across pathways and organisations to achieve lasting impact for patients, populations and the wider health and care system.

Rachel Surtees is Chief of Staff at UCLPartners, working with our Chief Executive to lead strategy development and delivery. Rachel also takes a lead on all of our corporate services including finance, HR, education, as well as the look and feel of our internal and external communications, organisational development and governance.

Rachel has worked in strategy and change roles across the NHS and local government for 15 years. Before joining UCLPartners, Rachel worked at the Tavistock and Portman NHS Foundation Trust for 10 years working up to becoming Director of Strategy and Transformation. Here she harnessed her specialist knowledge of mental health services in the UK to drive meaningful innovations. After working with Haringey Council and the Royal Free London NHS Foundation Trust, she bought these skills to UCLPartners as our Director of Implementation for our adolescent mental health and climate work.

Jinjer Kandola is an experienced NHS Chief Executive and has worked in both mental and physical healthcare for more than 35 years.

She has led two separate organisational mergers over the last two years to form the current North London NHS Foundation Trust, which provides all age mental health services across North London. Jinjer leads the organisation’s work to provide high quality care and maintain an overall ‘Good’ rating from the Care Quality Commission.

Jinjer is a member of the West and North London Integrated Care Board and the University College London Partners Board. At national level, she is a member of the NHS Employers Policy Board and the NHS / DHSC Social Partnership Forum.

The Health Service Journal (HSJ) has listed Jinjer as one of their Top 50 national Chief Executives for the last three years and she was awarded an MBE for services to mental health in 2021.

Sir Caulfield graduated in Medicine in 1984 from the London Hospital Medical College and trained in Clinical Pharmacology at St Bartholomew’s Hospital where he developed a research programme in molecular genetics of hypertension and translational clinical research.
At Queen Mary University of London Caulfield has made substantial contributions to the discovery of > 2000 gene regions related to blood pressure, cardiovascular health, cancer and rare diseases. His research has changed national and international guidance for high blood pressure. Caulfield was Director of Queen Mary’s William Harvey Research Institute between 2002-2020 and was elected to the Academy of Medical Sciences in 2008.
Sir Caulfield was appointed Chief Scientist for Genomics England in 2013 and delivered the 100,000 Genomes Project using whole genome sequencing in rare disease, cancer and infection from which he co-created the National Genomic Test Directory and a new Genomic Medicine Service. He was awarded a knighthood in 2019 for his leadership of the 100,000 Genomes Project.
In July 2021, Sir Mark stepped down from his role as Chief Scientist for Genomics England to lead Barts Life Sciences. This is driving the development of a world-leading life sciences campus at Whitechapel focusing on digital precision healthcare. He is a member of the Barts Health NHS Trust Board.

Professor Abubakar is a world-leading scholar in the field of infectious disease epidemiology. He brings significant global health experience to the position. From key chairing roles for World Health Organisation, to leading Lancet Migration, his expertise and advocacy have directly shaped policy implementation, affecting the lives of millions of people internationally, particularly in relation to tuberculosis and Covid 19. He joined UCL in 2012 as Professor of Infectious Disease Epidemiology and went on to become Director of the Institute of Global Health and Vice-Dean (International and External Engagement).  He was Pro-Provost (Health) and Dean of the Faculty of Population Health until 2025.

Shane was a Physiotherapist in his native Australia, working clinically and managerially in public hospitals and private practice in Adelaide. He came to the UK in 1996 where he obtained an MSc in TOC improvement methodology. He was a graduate of the NHS London Next Generation Chief Executive programme and held several Executive director posts at Board level, including at Epsom and St Helier University Hospitals NHS Trust and Barnet and Chase Farm Hospitals NHS Trust.
Shane was CEO of The Hillingdon Hospitals NHS Foundation Trust for six years and then moved across London to be Group Deputy CEO at Barts Health for the next four years, leading on the operational performance of one of the largest five-strong hospital groups in the UK. Shane took up the Group CEO role on 1 August 2022.  Shane was nominated as Chair of the Association of NHS Groups in 2025.

Tim Jaggard was first appointed to the UCLH Board in 2015 and previously held the post of deputy finance director at UCLH. He joined from the Whittington in 2010 where he was deputy finance director for two years. Tim has a degree in Psychology which was followed by further study at the Judge Business School, both in Cambridge.
He graduated from the NHS graduate training scheme in 2006 and held senior finance positions across a number of organisations within North Central London prior to joining UCLH. Tim held the finance lead role for the North London Partners Integrated Care System for a number of years prior to the establishment of the Integrated Care Board and continues to take a strong interest in system leadership and partnership working.
Tim has also been a non-executive director on the Board of a public-private pathology partnership, providing pathology services to NHS and private hospitals. He is now a member of the General Pharmaceutical council.

Pete joined the Royal Free London NHS Foundation Trust in April 2022 as Chief Delivery Officer. He was appointed as Interim Group Chief Executive in April 2023 and appointed as Group Chief Executive in October 2023. A graduate of Cardiff University, Pete started his career as a Management Consultant in PricewaterhouseCoopers, before joining the NHS in 2003. He worked in Cardiff and Vale University Health Board for more than 10 years and held senior operational management roles across community, secondary and tertiary services, including leadership at a national level for several specialist services in Wales. In 2015 Pete joined Western Sussex Hospitals, where he was Chief Operating Officer, before going on to be appointed as one of the Group Executives of both the Western and Brighton & Sussex Trusts in 2017. He was part of the team that led Western Sussex Hospitals Trust to be the first general acute Trust to achieve a CQC ‘Outstanding’ rating in all domains also helped significantly improve Brighton and Sussex University Hospitals Trust exiting special measures, overseeing the planning and delivery of the £500m new hospital, and leading on the merger of the two trusts in 2021.

Peter joined Moorfields Eye Hospital in January 2025 as interim chief executive and was appointed to the permanent role in October 2025. Prior to this, he served as chief officer at Portsmouth University Hospital NHS Trust, where he was responsible for delivery of the operating plan and organisational strategy.
He brings extensive NHS experience, having held a range of senior leadership roles. Previous positions include deputy chief finance officer at NHS England and group chief finance officer at the Royal Free London, where he also held board-level responsibilities covering strategy, performance and analytics. Earlier in his career, Peter worked at the Royal Surrey County Hospital and the Royal Marsden.
Throughout his career, Peter has demonstrated a strong commitment to staff development and engagement. Notably, he led the national One NHS Finance programme while at NHS England, supporting the development of finance professionals across the service.